What is Arcus Biosciences's change in other liabilities?

Arcus Biosciences (RCUS) reported change in other liabilities of -$16M in Q1 2026.

How has Arcus Biosciences's change in other liabilities changed year-over-year?

Arcus Biosciences's change in other liabilities increased by 5.9% year-over-year, from -$17M to -$16M.

What does change in other liabilities mean?

Change in miscellaneous liabilities affecting operating cash flow.

Arcus Biosciences RCUS Change in Other Liabilities

Change in Other Liabilities at other companies

Merck & Co.MRK

$48.75M+498%

Summit TherapeuticsSMMT

-$33K-232%

Cogent Biosciences, Inc.COGT

$29K+480%

CRISPR TherapeuticsCRSP

-$199K+98.1%

Jazz PharmaceuticalsJAZZ

$12.2M+321%

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.54B+226%

Enterprise value$3.46B+275%

P/S15×+7.3×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's change in other liabilities?: Arcus Biosciences (RCUS) reported change in other liabilities of -$16M in Q1 2026.
How has Arcus Biosciences's change in other liabilities changed year-over-year?: Arcus Biosciences's change in other liabilities increased by 5.9% year-over-year, from -$17M to -$16M.
What does change in other liabilities mean?: Change in miscellaneous liabilities affecting operating cash flow.